Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01907334 · ClinicalTrials.gov registry record · Phase 4
Dose-Response of Salmeterol in Children
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT01907334: Completed Phase 4 study, sponsored by University of Florida.
NCT01907334 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01907334, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
To examine whether a breathing test (methacholine challenge using impulse oscillometry) can be used to tell the difference between two different doses of an inhaled drug, salmeterol, delivered by Advair in children with asthma
Primary Outcome
concentration of methacholine required to increase total airway resistance by 40% (PC40R5)
Interventions
- DRUG Albuterol
- DRUG Advair Diskus100/50 µg
- DRUG Flovent Diskus 100 µg
- DRUG Methacholine Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
What the finished NCT01907334 record still lists
NCT01907334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Albuterol is the first listed.
NCT01907334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01907334 about?
NCT01907334 is a clinical study titled "Dose-Response of Salmeterol in Children". To examine whether a breathing test (methacholine challenge using impulse oscillometry) can be used to tell the difference between two different doses of an inhaled drug, salmeterol, delivered by Advair in children with asthma
What is the current status of trial NCT01907334?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01907334?
The interventions under investigation include: Albuterol (DRUG), Advair Diskus100/50 µg (DRUG), Flovent Diskus 100 µg (DRUG), Methacholine Chloride (DRUG).
Who is sponsoring clinical trial NCT01907334?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01907334's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia